Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology

M. Ries, H. Watts, B.C. Mota, M.Y. Lopez, C.K. Donat, N. Baxan, J.A. Pickering, T.W. Chau, A. Semmler, B. Gurung, R. Aleksynas, L. Abelleira-Hervas, S.J. Iqbal, C. Romero-Molina, G. Hernandez-Mir, A. D'Amati, C. Reutelingsperger, M.H. Goldfinger, S.M. Gentleman, F. Van LeuvenE. Solito, M. Sastre*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1526-1541
Number of pages16
JournalBrain
Volume144
DOIs
Publication statusPublished - 1 May 2021

Keywords

  • A beta
  • BBB
  • ANXA1
  • IDE
  • tau
  • BLOOD-BRAIN-BARRIER
  • NONSTEROIDAL ANTIINFLAMMATORY DRUGS
  • ALZHEIMERS-DISEASE
  • IN-VIVO
  • TRANSGENIC MICE
  • MOUSE MODEL
  • PRECURSOR PROTEIN
  • NEURODEGENERATION
  • AQUAPORIN-4
  • ACTIVATION

Cite this